Acreage Holdings Inc
OTC:ACRDF

Watchlist Manager
Acreage Holdings Inc Logo
Acreage Holdings Inc
OTC:ACRDF
Watchlist
Price: 0.122 USD -3.17%
Market Cap: 9.9m USD

Relative Value

There is not enough data to reliably calculate the relative value of ACRDF.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACRDF Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0.1
Median 5Y
0.2
Industry
2.6
Forward
0
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.4
Industry
21.6
Forward
-4.6
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-1.5
Industry
16.5
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
22.5
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
0.5
Industry
2.3
vs History
vs Industry
Median 3Y
1.3
Median 5Y
1.4
Industry
2.9
Forward
1.1
vs History
vs Industry
Median 3Y
2.8
Median 5Y
3.1
Industry
5.5
vs History
vs Industry
Median 3Y
-6.7
Median 5Y
-4.8
Industry
13
vs History
vs Industry
Median 3Y
-7.9
Median 5Y
-7.2
Industry
16.6
vs History
vs Industry
Median 3Y
-15.9
Median 5Y
-6.1
Industry
15.8
vs History
vs Industry
Median 3Y
-7
Median 5Y
-4.4
Industry
19.1
vs History
vs Industry
Median 3Y
0.9
Median 5Y
0.8
Industry
1.9

Multiples Across Competitors

ACRDF Competitors Multiples
Acreage Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Acreage Holdings Inc
OTC:ACRDF
9.9m USD 0.1 -0.1 -6.7 -7.1
US
Eli Lilly and Co
NYSE:LLY
996.4B USD 16.8 54.1 36.3 38.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
503.4B USD 5.5 20 16.4 21.2
CH
Roche Holding AG
SIX:ROG
252.6B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
211.6B GBP 4.9 30.2 108.7 159.1
CH
Novartis AG
SIX:NOVN
207.5B CHF 4.7 18.1 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
244.9B USD 3.8 12.8 9.2 10.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.2 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.5 7.4 10.2
P/E Multiple
Earnings Growth PEG
US
Acreage Holdings Inc
OTC:ACRDF
Average P/E: 23.7
Negative Multiple: -0.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.1
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
12.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.5
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Acreage Holdings Inc
OTC:ACRDF
Average EV/EBITDA: 438.8
Negative Multiple: -6.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.3
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Acreage Holdings Inc
OTC:ACRDF
Average EV/EBIT: 1 881.2
Negative Multiple: -7.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.2
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
159.1
23%
6.9
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.9
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3